HK Al-Hakeim, AK Abed, SR Moustafa, AF Almulla… - medRxiv, 2023 - medrxiv.org
Background Critical COVID-19 disease is accompanied by depletion of plasma tryptophan (TRY) and increases in indoleamine-dioxygenase (IDO)-stimulated production of …
HK Al-Hakeim, AK Abed, SR Moustafa… - Frontiers in …, 2023 - search.ebscohost.com
Critical COVID-19 disease is accompanied by depletion of plasma tryptophan (TRY) and increases in indoleamine-dioxygenase (IDO)-stimulated production of neuroactive …
HK Al-Hakeim, AK Abed, SR Moustafa, AF Almulla… - 2023 - researchgate.net
After the COVID-19 pandemic, which caused millions of acute cases and millions of deaths, healthcare professionals are facing another crisis due to the development and/or …
HK Al-Hakeim, AK Abed, SR Moustafa, AF Almulla… - 2023 - scienceopen.com
After the COVID-19 pandemic, which caused millions of acute cases and millions of deaths, healthcare professionals are facing another crisis due to the development and/or …
HK Al-Hakeim, AK Abed, SR Moustafa… - Frontiers in …, 2023 - search.proquest.com
Critical COVID-19 disease is accompanied by depletion of plasma tryptophan (TRY) and increases in indoleamine-dioxygenase (IDO)-stimulated production of neuroactive …
HK Al-Hakeim, A Khairi Abed, S Rouf Moustafa… - 2023 - dro.deakin.edu.au
Critical COVID-19 disease is accompanied by depletion of plasma tryptophan (TRY) and increases in indoleamine-dioxygenase (IDO)-stimulated production of neuroactive …
HK Al-Hakeim, AK Abed, SR Moustafa, AF Almulla… - 2023 - europepmc.org
Background Critical COVID-19 disease is accompanied by depletion of plasma tryptophan (TRY) and increases in indoleamine-dioxygenase (IDO)-stimulated production of …
HK Al-Hakeim, AK Abed, SR Moustafa… - Frontiers in Molecular …, 2023 - ncbi.nlm.nih.gov
Critical COVID-19 disease is accompanied by depletion of plasma tryptophan (TRY) and increases in indoleamine-dioxygenase (IDO)-stimulated production of neuroactive …
HK Al-Hakeim, AK Abed… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Critical COVID-19 disease is accompanied by depletion of plasma tryptophan (TRY) and increases in indoleamine-dioxygenase (IDO)-stimulated production of neuroactive …